Conservation of Virally Encoded MicroRNAs in Kaposi Sarcoma–Associated Herpesvirus in Primary Effusion Lymphoma Cell Lines and in Patients with Kaposi Sarcoma or Multicentric Castleman Disease
The Journal of Infectious Diseases2007Vol. 195(5), pp. 645–659
Citations Over TimeTop 10% of 2007 papers
Vickie Marshall, Thomas L. Parks, Rachel Bagni, Cheng Dian Wang, Mark A. Samols, Jianhong Hu, Kathleen M. Wyvil, Karen Aleman, Richard F. Little, Robert Yarchoan, Rolf Renne, Denise Whitby
Abstract
These data demonstrate that KSHV microRNA genes are under tight selection in vivo and suggest that they contribute to the biological activity and possibly the pathogenesis of KSHV-associated malignancies.
Related Papers
- → Regulation of KSHV Latency and Lytic Reactivation(2020)130 cited
- → Celecoxib Inhibits the Lytic Activation of Kaposi’s Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPK(2015)20 cited
- → HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling(2016)26 cited
- → Role of Defective Oct-2 and OCA-B Expression in Immunoglobulin Production and Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation in Primary Effusion Lymphoma(2009)17 cited
- → Kaposi's sarcoma-associated herpesvirus-encoded LANA associates with glucocorticoid receptor and enhances its transcriptional activities(2015)5 cited